September 29, 2019

ESMO Sept 29 Unravelling the biological characteristics of MammaPrint

AUTHORS:

Rajith Bhaskaran, Christian J Griffioen, Diedrik Wehkamp, Lorenza Mittempergher and Annuska M Glas

DESCRIPTION:

Unravelling the biological characteristics of MammaPrint extreme risk subgroups

MammaPrint®(MP) is a 70-gene based prognostic assay that stratifies early-stage breast cancer patients into low and high-risk of relapse. Recently, further stratification of the 70-gene risk results identified extreme low and high-risk subgroups with specific clinical outcomes (Delahaye et al. 2017) and treatment response characteristics (Wolf et al. 2017).

Read more: ESMO Sept 29 Unravelling the biological characteristics of MammaPrint